medicalxpress.com
Researchers have identified 13 genes that significantly increase the risk of developing osteoarthritis, potentially opening paths to targeted therapies.
Understanding genetic factors in osteoarthritis is essential for developing therapies that could halt disease progression, impacting millions worldwide.
A recent study conducted by the UNC Thurston Arthritis Research Center has successfully identified 13 genes linked with a heightened risk of developing osteoarthritis. This breakthrough, detailed in Cell Genomics, fills a critical gap in genetic research related to the disease. Among the 13 genes, six were previously unassociated with osteoarthritis, offering fresh insights into the biological processes causing joint degeneration. The study's goal is to target these genetic factors with therapies that could prevent further joint damage. Researchers plan ongoing gene studies and drug testing to identify compounds that may impact the disease's progression. The research, which began in 2022, involved collecting joint tissue from over 100 donors and utilizing advanced genomics to analyze the genetic data.
Osteoarthritis is largely influenced by genetic factors, making genetic research crucial for understanding the disease.
Identifying specific genes allows for targeted approaches to treatment and prevention.
By establishing a causal link between specific genes and osteoarthritis, researchers can focus on these genes for therapeutic development.
Osteoarthritis is a common joint disease affecting millions. While many factors contribute to its development, genetics play a significant role. Recent studies suggest that nearly half of the risk for osteoarthritis is genetic, highlighting the importance of identifying specific genetic components.
“If we can identify the causal genes, we can use that information to define new genetic targets for therapies for osteoarthritis,” said Richard F. Loeser, Jr., MD.
Recognizing this genetic predisposition opens opportunities for developing targeted therapies that focus on these specific risk genes, potentially altering disease outcomes.
The identification of 13 genes provides a roadmap for developing therapies to address osteoarthritis at a genetic level.
With specific genetic targets identified, treatment strategies can be more precise and potentially more effective.
The identification of these genes directly supports developing targeted treatments, as therapies can be designed to interact with these specific genetic components.
A significant breakthrough in osteoarthritis research is the identification of 13 'high probability risk genes.' This discovery is pivotal as it not only pinpoints the genes involved but also highlights new potential targets for therapeutic development.
“Some of these genes have known roles in osteoarthritis or are involved in processes relevant to osteoarthritis pathology,” noted Doug Phanstiel, Ph.D.
These identified genes serve as crucial markers, guiding researchers in developing new treatments that could directly target and modify the course of the disease.
Identified genetic targets could reshape osteoarthritis treatment and prevention.
The research paves the way for developing new therapeutics that could halt osteoarthritis progression.
Understanding and targeting genetic factors can lead to more effective treatment strategies and possibly prevention.
By understanding the genetic pathways involved, researchers can infer potential therapeutic approaches that may alter disease progression.
The identification of these genetic markers means potential treatments that target these specific pathways could be developed, which may prevent further joint deterioration and the associated pain.
The team is already expanding their research to explore these genes further and understand their role in the disease's progression. Drug screening processes are underway to find compounds that influence these genetic pathways.
This foundational research sets the stage for a future where osteoarthritis treatment is not merely symptomatic but addresses the root causes of the disease at a genetic level.
Kramer, N. E., et al. (2025). Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis risk. Cell Genomics. DOI: 10.1016/j.xgen.2024.100738
Rovinsky, K. D. (2025). Study unveils 13 genes that increase the risk of osteoarthritis. Medical Xpress. Retrieved January 9, 2025, from https://medicalxpress.com/news/2025-01-unveils-genes-osteoarthritis.html